Stanford University
Showing 451-460 of 747 Results
-
Florian Hoffmann, Ph.D.
Postdoctoral Scholar, Hematology
BioFlorian is a postdoctoral researcher in Dr. Ami Bhatt's laboratory at Stanford University. He earned his Ph.D. in Biochemistry working in Dr. Sam Sternberg's group at Columbia University where he studied atypical CRISPR systems in prokaryotes, in search of molecular tools for programmable gene editing and gene regulation. His studies elucidate the mechanisms of a novel RNA-guided transposition system, the evolutionary ancestors of the gene editing enzymes Cas9 and Cas12, and an unprecedented Cas12f enzyme that creates custom de novo transcription start sites without requiring promoter elements. Florian is fascinated by the vast untapped resources of novel gene functions encoded in bacteria and their viruses (bacteriophages). He is an inventor on multiple patents related to his doctoral work. During his postdoctoral work at Stanford, he aims to discover novel paradigms of bacteria-virus interactions and how these shape the human gut microbiome, and human health. To investigate these systems, he harnesses interdisciplinary approaches, combining computational gene discovery with experimental techniques in Molecular Biology, Genetics and Biochemistry.
-
Manuel Hoffmann
Affiliate, Center for Population Health Sciences
Biowww.manuelhoffmann.org
-
Lawrence "Rusty" Hofmann, MD
Professor of Radiology (Interventional Radiology)
BioDr. Lawrence “Rusty” Hofmann is an actively practicing physician and Professor of Interventional Radiology at Stanford School of Medicine, as well as the Chief of Industry Partnerships for Stanford Healthcare, Medical Director of Cardiac and Interventional Services, and the Medical Director of Digital Health at Stanford Medicine. He served as Chief of Interventional Radiology at Stanford for nearly two decades. He is the Co-Founder of Grand Rounds, Inc, rebranded as Included Health. He has devoted his career to providing state-of-the-art care to patients at either Johns Hopkins, where he practiced for 10 years, or Stanford, where he practiced for 15 years. He has published over 100 scientific articles on minimally invasive treatment of blood clots (DVT) and cancer. He has always had in interest in innovation. He holds 2 patents, has worked as a consultant for numerous medical device companies, both start-ups and large companies and is currently the Global-Principal Investigator for the first clinical trial testing a venous stent. He has invented and brought a number of devices from napkin stage to world-wide use. He has active digital health research projects at the intersection of artificial intelligence and clinical care, including telemedicine and deep venous thrombosis.
